First-Line Chemotherapy for Metastatic Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference48 articles.
1. Natural history of untreated breast cancer (1805-1933): comparison of untreated and treated cases according to histological grade of malignancy;Bloom;Br Med J,1962
2. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer;Chia;Cancer,2007
3. Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer;Dawood;J Clin Oncol,2008
4. Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies;Gennari;Cancer,2005
5. Is breast cancer survival improving: trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000;Giordano;Cancer,2004
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bibliometric analysis and visualization of endocrine therapy for breast cancer research in the last two decade;Frontiers in Endocrinology;2023-12-05
2. Targeting tumor microenvironment of metastatic triple negative breast cancer cells via exosomes derived from non-invasive breast cancer cells for multi-drug resistance inhibition and enhancing drug susceptibility;Journal of Drug Delivery Science and Technology;2023-11
3. In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells;Journal of the Egyptian National Cancer Institute;2023-03-27
4. Deep learning-based multi-drug synergy prediction model for individually tailored anti-cancer therapies;Frontiers in Pharmacology;2022-12-15
5. Aspectos clínicos y terapéuticos del carcinoma de mama metastásico triple negativo;Anales Médicos de la Asociación Médica del Centro Médico ABC;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3